Annual report pursuant to Section 13 and 15(d)

Provision for Income Taxes - Additional Information (Detail)

v3.22.4
Provision for Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Aug. 16, 2022
Jul. 31, 2021
Aug. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Taxes Disclosure [Line Items]            
Operating loss carryforwards, limitations on use       Net federal operating loss carryforwards generated after January 1, 2018 may be carried forward indefinitely, subject to the 80% taxable income limitation on the utilization of the carryforwards.    
Research and development credit carry forward       $ 6,617 $ 4,632  
Tax rate       (9.93%) (4.36%)  
Increase in income tax provision       $ 177    
Unrecognized tax benefits netted against its deferred tax assets within other assets       1,650 $ 1,111 $ 720
Unrecognized tax benefits if recognized       1,511    
Tax due on pre-acquisition E&P, amount       1,353    
Amount of E&P subject to local tax       $ 6,763    
Local tax rate on distribution       20.00%    
Corporate alternative minimum tax 15.00%          
Excise tax on net share repurchases 1.00%          
Israeli [Member]            
Income Taxes Disclosure [Line Items]            
Tax rate   23.00% 12.00%      
Federal [Member]            
Income Taxes Disclosure [Line Items]            
Operating loss carry forward       $ 172,866    
Operating loss carry forwards expiration year       2034    
Research and development credit carry forward       $ 5,306    
Research and development credit expiration year         2036  
State [Member]            
Income Taxes Disclosure [Line Items]            
Operating loss carry forward       $ 122,346    
Operating loss carry forwards expiration year       2030    
Research and development credit carry forward       $ 3,573